Home › Diffuse Scleroderma › Massachusetts
Diffuse Scleroderma clinical trials in Massachusetts
5 studies for Diffuse Scleroderma are looking for participants at sites in Massachusetts.
Cities in Massachusetts
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- Brigham and Women's Hospital, Boston
- Boston Medical Center, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07287670A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- Boston Medical Center, Boston
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Aug 28, 2026 · NCT06925542Platform Clinical Study for Conquering Scleroderma
- Massachusetts General Hospital, Boston
- Boston University (BU), Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
- Shapiro Outpatient Rheumatology Clinic at Boston Medical Center, Boston
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT07090226A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Brigham And Womens Hospital, Boston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT07115745From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.